Results 91 to 100 of about 2,077 (188)
methods: The intensity of VVA symptoms was recorded for each patient. Patients were administered the Short Form 12 (SF-12) and the female sexual function index (FSFI) to assess quality of life and sexual function, respectively. An objective evaluation of
Salvatore, Stefano +21 more
core +1 more source
Plurigin Ovules and Plurigin Solution in the Treatment of Vulvovaginal Atrophy in Menopausal Women: A Retrospective Monocentric Observational Study. [PDF]
Langella D.
europepmc +1 more source
Objective: This study was designed to evaluate the use of low dose vaginal estriol and low dose vaginal estradiol creams for the treatment of vulvovaginal atrophy. Methods: We designed a 12-week randomized double blinded pilot study. Participants applied
Mac Bride, Maire Brid
core
Features of the vaginal microbiome in postmenopausal vulvovaginal atrophy
Objective: to study the features of the vaginal microbiome in women with postmenopausal OVA and to conduct a comparative analysis of the microbiota in groups with varying degrees of severity of symptoms.Materials and methods: a prospective study was ...
M. I. Biryukova +2 more
doaj +1 more source
A comparison of hyaluronic acid and estradiol treatment in vulvovaginal atrophy.
This study aims to compare the effects of vaginal estrogen and hyaluronic acid on vulvovaginal atrophy.This randomized controlled study included a total of 300 patients, with 150 patients in each group (Group E and Group H). The VHI score was determined based on a pre-treatment evaluation conducted by a gynecologist.
Jafarzade, A. +5 more
openaire +2 more sources
Vulvovaginal atrophy (VVA) is a condition frequently observed in menopause. Its symptoms can significantly affect the quality of life of patients. Since VVA is related to estrogen deficiency, chemotherapy and hormone therapy for breast cancer (BC) might ...
Schettini, Francesco +27 more
core +1 more source
New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review. [PDF]
Benini V +9 more
europepmc +1 more source
Sebastian Mirkin,1 James H Pickar21Pfizer Inc, Collegeville, PA, 2Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USAAbstract: Loss of estrogen production in women during menopause results in a state of estrogen
Mirkin S, Pickar JH
doaj
BackgroundPlatelet-rich plasma (PRP) is considered safe and is a low-cost, simple, natural, and minimally invasive method for vaginal rejuvenation. We aimed to compare the effects of hormonal treatment options and PRP use for postmenopausal vulvovaginal ...
Ufuk Atlihan +5 more
doaj +1 more source

